Literature DB >> 8218055

Prevention of intraocular pressure rise following intravitreal injection.

N Morlet1, S H Young.   

Abstract

The intraocular pressure change produced by an intravitreal injection of ganciclovir, 2 mg in 0.1 ml, was studied in patients with cytomegalovirus retinitis. Using a Tono-pen XL to measure the intraocular pressure (IOP) of four patients (six eyes) we found the mean pressure immediately following injection was 44.5 mm Hg. Measurements taken on separate occasions after a 30 mm Hg decompression of the eye for 15 minutes before the injection showed a mean IOP of only 20.6 mm Hg after the injection. Mercury bag decompression of the eye significantly reduced the rise in IOP following intravitreal injection (difference in the mean IOP rise = 26.4 mm Hg, df = 54, t = 7.67, p < 0.001). Without ocular decompression before injection, all patients complained of temporary loss of vision, and reflux of the injection solution was frequently observed. Use of ocular decompression also reduced the discomfort of the injection. Throughout the full course of treatment by this means there were no adverse effects on the visual acuity. This technique is recommended to those performing intravitreal injections.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8218055      PMCID: PMC513954          DOI: 10.1136/bjo.77.9.572

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


  10 in total

1.  Long-term intravitreal ganciclovir therapy for cytomegalovirus retinopathy.

Authors:  M H Heinemann
Journal:  Arch Ophthalmol       Date:  1989-12

2.  Comparison of the Tono-Pen to the Goldmann applanation tonometer.

Authors:  R E Frenkel; Y J Hong; D H Shin
Journal:  Arch Ophthalmol       Date:  1988-06

3.  Effect of ocular compression (Autopressor) on intraocular pressure in periocular anaesthesia.

Authors:  A Ropo; P Ruusuvaara; M Paloheimo; E L Maunuksela; P Nikki
Journal:  Acta Ophthalmol (Copenh)       Date:  1990-04

4.  Clinical evaluation of the Oculab Tono-Pen.

Authors:  D S Minckler; G Baerveldt; D K Heuer; B Quillen-Thomas; A F Walonker; J Weiner
Journal:  Am J Ophthalmol       Date:  1987-08-15       Impact factor: 5.258

5.  Effect of applying the Honan intraocular pressure reducer before cataract surgery.

Authors:  W M Jay; H Carter; B Williams; K Green
Journal:  Am J Ophthalmol       Date:  1985-10-15       Impact factor: 5.258

6.  Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results.

Authors:  H L Cantrill; K Henry; N H Melroe; W H Knobloch; R C Ramsay; H H Balfour
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

7.  High dose intravitreal ganciclovir in the treatment of cytomegalovirus retinitis.

Authors:  S H Young; N Morlet; S Heery; F C Hollows; M T Coroneo
Journal:  Med J Aust       Date:  1992-09-21       Impact factor: 7.738

8.  Efficacy and tolerance of intravitreal ganciclovir in cytomegalovirus retinitis in acquired immune deficiency syndrome.

Authors:  I Cochereau-Massin; P Lehoang; M Lautier-Frau; L Zazoun; P Marcel; M Robinet; S Matheron; C Katlama; S Gharakhanian; W Rozenbaum
Journal:  Ophthalmology       Date:  1991-09       Impact factor: 12.079

9.  The Tono-Pen. A manometric and clinical study.

Authors:  W A Boothe; D A Lee; W C Panek; T H Pettit
Journal:  Arch Ophthalmol       Date:  1988-09

10.  Clinical comparison of the Oculab Tono-Pen to the Goldmann applanation tonometer.

Authors:  S F Kao; P R Lichter; T J Bergstrom; S Rowe; D C Musch
Journal:  Ophthalmology       Date:  1987-12       Impact factor: 12.079

  10 in total
  9 in total

1.  Subconjunctival reflux and need for paracentesis after intravitreal injection of 0.1 ml bevacizumab: comparison between 27-gauge and 30-gauge needle.

Authors:  Katrin Lorenz; Isabella Zwiener; Alireza Mirshahi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2010-08-21       Impact factor: 3.117

2.  Purinergic control of vascular tone in the retina.

Authors:  Joanna Kur; Eric A Newman
Journal:  J Physiol       Date:  2013-11-25       Impact factor: 5.182

3.  High dose intravitreal ganciclovir injection provides a prolonged therapeutic intraocular concentration.

Authors:  N Morlet; S Young; D Naidoo; G Graham; M T Coroneo
Journal:  Br J Ophthalmol       Date:  1996-03       Impact factor: 4.638

4.  Reduction of Intraocular Pressure Spikes Due to Intravitreal Bevacizumab Injections by Scleral Indentation with Cotton Swab or Digital Ocular Massage: Innovative Techniques Compared.

Authors:  Raffaele Nuzzi; Simona Scalabrin; Alice Becco
Journal:  Clin Ophthalmol       Date:  2020-08-27

5.  High dose intravitreal ganciclovir for CMV retinitis: a shelf life and cost comparison study.

Authors:  N Morlet; S Young; D Naidoo; T Fong; M T Coroneo
Journal:  Br J Ophthalmol       Date:  1995-08       Impact factor: 4.638

6.  Time profile of viral DNA in aqueous humor samples of patients treated for varicella-zoster virus acute retinal necrosis by use of quantitative real-time PCR.

Authors:  D Bernheim; R Germi; M Labetoulle; J P Romanet; P Morand; C Chiquet
Journal:  J Clin Microbiol       Date:  2013-05-01       Impact factor: 5.948

7.  Intraocular pressure after peribulbar anaesthesia: is the Honan balloon necessary?

Authors:  J E Morgan; A Chandna
Journal:  Br J Ophthalmol       Date:  1995-01       Impact factor: 4.638

8.  Survey of Intravitreal Injection Techniques Among Retina Specialists in Mexico.

Authors:  Andree Henaine-Berra; Vanesa Flores-Peredo; Gabriela Lopezcarasa-Hernandez; Maria Ana Martinez-Castellanos; Ximena Mira-Lorenzo; Adriana Solis-Vivanco; Gerardo Garcia-Aguirre
Journal:  Clin Ophthalmol       Date:  2020-11-26

Review 9.  Intraocular Pressure rise after Anti-VEGF Treatment: Prevalence, Possible Mechanisms and Correlations.

Authors:  George Kampougeris; Dimitrios Spyropoulos; Adrianna Mitropoulou
Journal:  J Curr Glaucoma Pract       Date:  2013-01-15
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.